The Recql5 Helicase Is a Novel Downstream Target of Jak2V617F and Maintains Genome Stability in Response to Replication Stress

被引：9
|
作者：
Chen, Edwin [1 ]
Ahn, Jong-Sook [2 ]
Breyfogle, Lawrence J. [1 ]
Green, Anthony R. [2 ]
Ebert, Benjamin L. [1 ]
Mullally, Ann [1 ,3 ,4 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Univ Cambridge, Cambridge, England
[3] Broad Inst, Cambridge, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.4773.4773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cytogenetic profile, JAK2V617F mutational status, and response to drug therapy in myelofibrosis with myeloid metaplasia.
    Strand, JJ
    Lasho, TL
    Schwager, SM
    Elliott, MM
    Li, CY
    Tefferi, A
    BLOOD, 2005, 106 (11) : 729A - 729A
  • [42] Outcomes of Patients with Low Variant Allele Fraction JAK2V617F: A 5-Year Retrospective Analysis
    Limvorapitak, Wasithep
    Parker, Jeremy
    Foltz, Lynda
    Karsan, Aly
    BLOOD, 2018, 132
  • [43] Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation
    Nomdedeu, Meritxell
    Maffioli, Margherita
    Calvo, Xavier
    Martinez-Trillos, Alejandra
    Baumann, Tycho
    Diaz-Beya, Marina
    Aguilar, Josep-Lluis
    Rozman, Maria
    Costa, Dolors
    Esteve, Jordi
    Cervantes, Francisco
    Colomer, Dolors
    Nomdedeu, Benet
    LEUKEMIA RESEARCH, 2011, 35 (09) : 1276 - 1278
  • [44] Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab
    Maekawa, Takaaki
    Kato, Shoichiro
    Kawamura, Toshikuni
    Takada, Kohei
    Sone, Takehiro
    Ogata, Hiraku
    Saito, Keita
    Izumi, Takuya
    Nagao, Shigeki
    Takano, Kosuke
    Okada, Yosuke
    Tachi, Noriaki
    Teramoto, Masahiro
    Horiuchi, Toshikatsu
    Hikota-Saga, Reina
    Endo-Umeda, Kaori
    Uno, Shigeyuki
    Osawa, Yukiko
    Kobayashi, Ayako
    Kobayashi, Shinichi
    Sato, Ken
    Hashimoto, Michihiro
    Suzu, Shinya
    Usuki, Kensuke
    Morishita, Soji
    Araki, Marito
    Makishima, Makoto
    Komatsu, Norio
    Kimura, Fumihiko
    BLOOD, 2019, 134 (10) : 814 - 825
  • [45] Development and validation of a novel acute myeloid leukemia xenograft model that is dependent on the JAK2v617F mutation for growth in vivo
    Lee, Leslie
    Hanan, Emily
    Zhou, Aihe
    Rawson, Thomas
    Li, Ji
    Kholi, Pawan Bir
    Barrett, Kathy
    Chang, Christine
    Chen, Jacob
    Ubhayakar, Savita
    Siu, Mike
    Kenny, Jane
    Blair, Wade
    Ghilardi, Nico
    Sampath, Deepak
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [46] Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms
    Bracco, Enrico
    Rosso, Valentina
    Serra, Anna
    Carnuccio, Francesca
    Gaidano, Valentina
    Nicoli, Paolo
    Musto, Pellegrino
    Saglio, Giuseppe
    Frassoni, Francesco
    Cilloni, Daniela
    BMC CANCER, 2013, 13
  • [47] JAK2V617F mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones
    Sokol, L.
    Caceres, G.
    Rocha, K.
    Stockero, K. J.
    Dewald, D. W.
    List, A. F.
    LEUKEMIA RESEARCH, 2010, 34 (06) : 821 - 823
  • [48] Lenalidomide therapy in del(5)(q31)-associated myelofibrosis:: cytogenetic and JAK2V617F molecular remissions
    Tefferi, A.
    Lasho, T. L.
    Mesa, R. A.
    Pardanani, A.
    Ketterling, R. P.
    Hanson, C. A.
    LEUKEMIA, 2007, 21 (08) : 1827 - 1828
  • [49] Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions
    A Tefferi
    T L Lasho
    R A Mesa
    A Pardanani
    R P Ketterling
    C A Hanson
    Leukemia, 2007, 21 : 1827 - 1828
  • [50] JAK2V617F Molecular Response to Ruxolitinib in Patients with PV and ET Is Associated with Lower Risk of Progression to Secondary Myelofibrosis
    Guglielmelli, Paola
    Mora, Barbara
    Gesullo, Francesca
    Mannelli, Francesco
    Loscocco, Giuseppe Gaetano
    Signori, Leonardo
    Pessina, Chiara
    Pancani, Fabiana
    Colugnat, Ilaria
    Aquila, Raffaela
    Nacca, Elena
    Cicogna, Paolo
    Passamonti, Francesco
    Vannucchi, Alessandro
    BLOOD, 2022, 140 : 1788 - 1789
12345